Literature DB >> 8637205

Carcinoma of the ampulla of Vater: is radical lymphadenectomy beneficial to patients with nodal disease?

Y Shirai1, K Tsukada, T Ohtani, K Hatakeyama.   

Abstract

This study was undertaken to evaluate the effectiveness of radical lymphadenectomy in ampullary cancer with nodal disease. Thirty-five patients underwent the Whipple procedure with radical lymphadenectomy. The location and number of positive nodes was characterized. Eighteen patients (51%) had positive nodes. Patients without nodal disease (pN0 group) had an actuarial 5-year survival rate of 81%. Seven patients with metastasis confined to the pancreaticoduodenal nodes had a 5-year survival rate of 67%, which was comparable for the pN0 group (N.S.) and better than the 27% 5-year survival rate in patients with positive superior mesenteric nodes (P<0.05). Eleven patients with one to three positive nodes had a 5-year survival rate of 71%, which was also comparable to the pN0 group (N.S.) and better than the 0% 5-year survival rate in patients with four or more positive nodes (P<0.01). Radical lymphadenectomy is effective against a limited degree of nodal disease.

Entities:  

Mesh:

Year:  1996        PMID: 8637205     DOI: 10.1002/(SICI)1096-9098(199603)61:3<190::AID-JSO5>3.0.CO;2-6

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  7 in total

1.  Clinical significance of lymph node micrometastasis in ampullary carcinoma.

Authors:  Eiko Sakata; Yoshio Shirai; Naoyuki Yokoyama; Toshifumi Wakai; Jun Sakata; Katsuyoshi Hatakeyama
Journal:  World J Surg       Date:  2006-06       Impact factor: 3.352

2.  Adenocarcinoma of the ampulla of Vater. A 28-year experience.

Authors:  M A Talamini; R C Moesinger; H A Pitt; T A Sohn; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1997-05       Impact factor: 12.969

3.  Jaundice at presentation heralds advanced disease and poor prognosis in patients with ampullary carcinoma.

Authors:  Naoyuki Yokoyama; Yoshio Shirai; Toshifumi Wakai; Shigenori Nagakura; Kohei Akazawa; Katsuyoshi Hatakeyama
Journal:  World J Surg       Date:  2005-04       Impact factor: 3.352

4.  Assessment of the nodal status in ampullary carcinoma: the number of positive lymph nodes versus the lymph node ratio.

Authors:  Jun Sakata; Yoshio Shirai; Toshifumi Wakai; Yoichi Ajioka; Kouhei Akazawa; Katsuyoshi Hatakeyama
Journal:  World J Surg       Date:  2011-09       Impact factor: 3.352

5.  Clinicopathologic analysis of early ampullary cancers with a focus on the feasibility of ampullectomy.

Authors:  Yoo-Seok Yoon; Sun-Whe Kim; Sang Jae Park; Hye Seung Lee; Jin-Young Jang; Min Gew Choi; Woo Ho Kim; Kuhn-Uk Lee; Yong-Hyun Park
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

6.  Determining the Adequate Examined Lymph Node Count in Resected Ampullary Adenocarcinoma-A National Cohort Study.

Authors:  Ibrahim Nassour; Alana Christie; Michael A Choti; John C Mansour; Rebecca M Minter; Patricio M Polanco; Mathew M Augustine; Matthew R Porembka; Xian-Jin Xie; Sam C Wang
Journal:  J Gastrointest Surg       Date:  2018-03-15       Impact factor: 3.452

7.  Adenocarcinoma of the ampulla of Vater: T-stage, chromosome 17p allelic loss, and extended pancreaticoduodenectomy are relevant prognostic factors.

Authors:  Calogero Iacono; Giuseppe Verlato; Giuseppe Zamboni; Aldo Scarpa; Ettore Montresor; Paola Capelli; Luca Bortolasi; Giovanni Serio
Journal:  J Gastrointest Surg       Date:  2007-05       Impact factor: 3.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.